Literature DB >> 8702630

Conformational changes and stabilization of inosine 5'-monophosphate dehydrogenase associated with ligand binding and inhibition by mycophenolic acid.

E Nimmesgern1, T Fox, M A Fleming, J A Thomson.   

Abstract

The effects of substrate, product, and inhibitor (mycophenolic acid) binding on the conformation and stability of hamster type II inosine 5'-monophosphate dehydrogenase (IMPDH) have been examined. The protein in various states of ligand occupancy was compared by analyzing susceptibility to in vitro proteolysis, the degree of binding of a hydrophobic fluorescent dye, secondary structure content as determined by far-UV circular dichroism spectra, and urea-induced denaturation curves. These analysis methods revealed consistent evidence that IMPDH undergoes a local reorganization when IMP or XMP bind. NAD+ produced no such effect. In fact, no evidence was found for NAD+ binding independently of IMP. It is proposed that IMPDH adopts an open conformation around its nucleotide binding sites in the absence of substrates and that binding of IMP stabilizes a closed conformation that has a higher affinity for NAD+. The data also suggest the enzyme remains in the closed configuration throughout the catalytic steps and then reverts to the open conformation with XMP release, thereby consummating the enzyme cycle. Mycophenolic acid inhibition appeared to impart even greater stability. We propose that localized conformational changes occur during the normal and mycophenolic acid-inhibited reaction sequences of IMPDH.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8702630     DOI: 10.1074/jbc.271.32.19421

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

Review 1.  IMP dehydrogenase: structure, mechanism, and inhibition.

Authors:  Lizbeth Hedstrom
Journal:  Chem Rev       Date:  2009-07       Impact factor: 60.622

2.  Crystal structure of human type II inosine monophosphate dehydrogenase: implications for ligand binding and drug design.

Authors:  T D Colby; K Vanderveen; M D Strickler; G D Markham; B M Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

3.  The cystathionine-β-synthase domains on the guanosine 5''-monophosphate reductase and inosine 5'-monophosphate dehydrogenase enzymes from Leishmania regulate enzymatic activity in response to guanylate and adenylate nucleotide levels.

Authors:  Sabrina Smith; Jan Boitz; Ehzilan Subramanian Chidambaram; Abhishek Chatterjee; Maria Ait-Tihyaty; Buddy Ullman; Armando Jardim
Journal:  Mol Microbiol       Date:  2016-03-10       Impact factor: 3.501

4.  Allosteric activation via kinetic control: potassium accelerates a conformational change in IMP dehydrogenase.

Authors:  Thomas V Riera; Lianqing Zheng; Helen R Josephine; Donghong Min; Wei Yang; Lizbeth Hedstrom
Journal:  Biochemistry       Date:  2011-09-09       Impact factor: 3.162

5.  Consistent inhibition of HIV-1 replication in CD4+ T cells by acyclovir without detection of human herpesviruses.

Authors:  Moira A McMahon; Teresa L Parsons; Lin Shen; Janet D Siliciano; Robert F Siliciano
Journal:  J Virol       Date:  2011-02-16       Impact factor: 5.103

6.  The antiherpesvirus activity of H2G [(R)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine] is markedly enhanced by the novel immunosuppressive agent mycophenolate mofetil.

Authors:  J Neyts; G Andrei; E De Clercq
Journal:  Antimicrob Agents Chemother       Date:  1998-12       Impact factor: 5.191

7.  Spectroscopy and Molecular Modeling Study on the Interaction Between Mycophenolate Mofetil and Pepsin.

Authors:  Xiaoli Ma; Liuqi Guo; Qing Wang; Jiawei He; Hui Li
Journal:  J Fluoresc       Date:  2015-12-16       Impact factor: 2.217

8.  Different characteristics and nucleotide binding properties of inosine monophosphate dehydrogenase (IMPDH) isoforms.

Authors:  Elaine C Thomas; Jennifer H Gunter; Julie A Webster; Nicole L Schieber; Viola Oorschot; Robert G Parton; Jonathan P Whitehead
Journal:  PLoS One       Date:  2012-12-07       Impact factor: 3.240

9.  4-Pyridone-3-carboxamide-1-β-D-ribonucleoside triphosphate (4PyTP), a novel NAD metabolite accumulating in erythrocytes of uremic children: a biomarker for a toxic NAD analogue in other tissues?

Authors:  Elena Synesiou; Lynnette D Fairbanks; H Anne Simmonds; Ewa M Slominska; Ryszard T Smolenski; Elizabeth A Carrey
Journal:  Toxins (Basel)       Date:  2011-06-07       Impact factor: 4.546

10.  Myc-dependent purine biosynthesis affects nucleolar stress and therapy response in prostate cancer.

Authors:  Stefan J Barfeld; Ladan Fazli; Margareta Persson; Lisette Marjavaara; Alfonso Urbanucci; Kirsi M Kaukoniemi; Paul S Rennie; Yvonne Ceder; Andrei Chabes; Tapio Visakorpi; Ian G Mills
Journal:  Oncotarget       Date:  2015-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.